DailyHum Logo
Cramer's lightning round: Nucor is a buy
Sep 23, 2021 | CNBC
Picture - Cramer's lightning round: Nucor is a buy

Dynavax Technologies Corp.: "Yeah, well, it's good. I love these little immuno drug stories."

Nucor Corp.: Buy. "Nucor is coming back. ... People think it's going to earn $22 [per share] this year and $11 next year. It's probably going to earn $20 next year, and the stock sells at 5 times earnings. It should sell at 10 times earnings. That means you're going to get a double if you hold onto Nucor. I really believe that. I know most people don't."

Amarin Corp.: "OK. Let's just describe this. This is a $5 stock that might get a bid or might go to zero, and that's how you have to look at. Interesting risk/reward."

Disclaimer

Questions for Cramer? Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up! Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Sponsored
8 hours ago | Bloomberg
China Risks Deeper Slowdown
9 hours ago | The NY Times
Inside the Big Facebook Leak
11 hours ago | Entrepreneur
9 Tips for Finding Your Life Purpose
3 trends driving data observability
Oct 22, 2021 | Venture Beat
AI/ML
4 things VCs get wrong about AI
21 hours ago | Venture Beat
AI/ML